Near Future Directions: Promising Strategies Under Investigation

Download this slideset from a live symposium at ASH 2022 to review emerging investigational agents and combination therapies in CLL.
person default
Deborah Stephens, DO
File Size: 8,185 KB
Released: December 9, 2022

Acknowledgements

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC
NCCN Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
AstraZeneca
BeiGene
Lilly
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings